130 related articles for article (PubMed ID: 15196588)
1. Development and in vivo evaluation of an oral insulin-PEG delivery system.
Calceti P; Salmaso S; Walker G; Bernkop-Schnürch A
Eur J Pharm Sci; 2004 Jul; 22(4):315-23. PubMed ID: 15196588
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of monomethoxypoly(ethylene glycol)-insulin conjugates.
Zhang M; Dou H; Yin L; Zhang Y; Zhu S; Yin C
Pharmazie; 2009 Mar; 64(3):190-6. PubMed ID: 19348342
[TBL] [Abstract][Full Text] [Related]
3. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin.
Morçöl T; Nagappan P; Nerenbaum L; Mitchell A; Bell SJ
Int J Pharm; 2004 Jun; 277(1-2):91-7. PubMed ID: 15158972
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
Salmaso S; Bersani S; Elvassore N; Bertucco A; Caliceti P
Int J Pharm; 2009 Sep; 379(1):51-8. PubMed ID: 19545616
[TBL] [Abstract][Full Text] [Related]
5. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
Kumar A; Lahiri SS; Singh H
Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
Damgé C; Maincent P; Ubrich N
J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
[TBL] [Abstract][Full Text] [Related]
7. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
9. Reversible pegylation of insulin facilitates its prolonged action in vivo.
Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery.
Chae SY; Jin CH; Shin HJ; Youn YS; Lee S; Lee KC
Bioconjug Chem; 2008 Jan; 19(1):334-41. PubMed ID: 18078308
[TBL] [Abstract][Full Text] [Related]
11. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
12. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled "nanocubicle" as a carrier for peroral insulin delivery.
Chung H; Kim J; Um JY; Kwon IC; Jeong SY
Diabetologia; 2002 Mar; 45(3):448-51. PubMed ID: 11914752
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of a novel oral insulin formulation.
Ma EL; Ma H; Liu Z; Zheng GX; Duan MX
Acta Pharmacol Sin; 2006 Oct; 27(10):1382-8. PubMed ID: 17007747
[TBL] [Abstract][Full Text] [Related]
15. PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice.
Youn YS; Jeon JE; Chae SY; Lee S; Lee KC
Diabetes Obes Metab; 2008 Apr; 10(4):343-6. PubMed ID: 18034839
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of insulin using chitosan capsules cross-linked with phytic acid.
Lee H; Jeong C; Ghafoor K; Cho S; Park J
Biomed Mater Eng; 2011; 21(1):25-36. PubMed ID: 21537061
[TBL] [Abstract][Full Text] [Related]
17. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
18. Glucose-induced release of glycosylpoly(ethylene glycol) insulin bound to a soluble conjugate of concanavalin A.
Liu F; Song SC; Mix D; Baudys M; Kim SW
Bioconjug Chem; 1997; 8(5):664-72. PubMed ID: 9327129
[TBL] [Abstract][Full Text] [Related]
19. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
20. Insulin-loaded microcapsules for in vivo delivery.
Kim BS; Oh JM; Hyun H; Kim KS; Lee SH; Kim YH; Park K; Lee HB; Kim MS
Mol Pharm; 2009; 6(2):353-65. PubMed ID: 19718792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
